AI assistant
Sending…
Equillium, Inc. — Director's Dealing 2021
Jan 13, 2021
34270_dirs_2021-01-13_1480595f-71e4-44cd-9c5e-65c4ac99899c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Equillium, Inc. (EQ)
CIK: 0001746466
Period of Report: 2021-01-11
Reporting Person: Thomas Dolca (Chief Medical Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities are beneficially owned | 0 | Direct |
More from Equillium, Inc.
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 25
Annual Report
2026
Mar 25
Major Shareholding Notification
2026
Mar 20
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9